Atlas Trials

Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma

Clinical trial NCT04447326 · UNKNOWN

Trial details

NCT number
NCT04447326
Sponsor
First Affiliated Hospital of Guangxi Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2020-06-01
Primary completion
2024-06-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.